Newly Diagnosed and Recurrent Glioblastoma
1 clinical trials · Condition
◉ Watch Newly Diagnosed and Recurrent Glioblastoma
| Record | Firm | Date |
|---|---|---|
| Dose Finding Study of [177Lu]Lu-NeoB in Newly Diagnosed Glioblastoma and in Recurrent Glioblastoma (NCT05739942) | Novartis Pharmaceuticals | 2024-05-15 |
Track Newly Diagnosed and Recurrent Glioblastoma automatically
Every clearance here is in the API, with alerts when new ones post.